A new 5mL dosing syringe delivering up to 500mg of levetiracetam (Keppra and Levetiracetam UCB) oral solution used in children aged 6 months to 4 years (150mL bottle), will replace the 3mL dosing syringe of levetiracetam, delivering up to 300mg levetiracetam.

This change may pose a risk of medication error and overdose: therefore, caregivers should be informed and instructed on the correct dosage and use of the new syringe.

Healthcare professionals are reminded of the importance of reporting suspected adverse reactions to ensure continuous monitoring of medicines safety and to protect patient health.